The Nonpsychoactive Cannabis Constituent Cannabidiol Is a Wake-Inducing Agent
- Eric Murillo-Rodríguez(corresponding author),
- Diana Millán-Aldaco,
- Marcela Palomero-Rivero,
- Raphael Mechoulam,
- René Drucker-Colín
- Universidad Autónoma de Campeche,
- Universidad Nacional Autónoma de México,
- Hebrew University of Jerusalem
Research Output:
Contribution to journal
Article
Peer-reviewPublication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 1378-1382 (5 pages)Journal (Volume, Issue Number)
Behavioral Neuroscience (Volume 122, Issue 6)Publication milestones
- Published - 01/12/2008
Publication status
Published - 01/12/2008
ISSN
0735-7044Publication IDs
- Scopus: 57049154057
- PubMed: 19045957
Abstract
Cannabidiol (CBD) is a constituent of Cannabis sativa that induces nonpsychotropic effects, and some of its biological actions in sleep have been described by the authors' group. Here, the authors report that when administered 10 or 20 μg/1 μl during the lights-on period directly into either lateral hypothalamus (LH) or dorsal raphe nuclei (DRN), which are wake-inducing brain areas, CBD enhanced wakefulness and decreased slow wave sleep and REM sleep. Furthermore, CBD increased alpha and theta power spectra but diminished delta power spectra. Additionally, CBD increased c-Fos expression in LH or DRN. These findings suggest that this cannabinoid is a wake-inducing compound that presumably activates neurons in LH and DRN.
Access to documents
Publication metrics
Metrics
SciVal
FWCI
0.28
PlumX, opens in new tab
46
Mentions
10
Captures
101
